BIOLIDICS LIMITED

(Company Registration Number: 200913076M)

RESPONSE TO QUERIES BY SGX REGCO

ON THE COMPANY'S ANNOUNCEMENTS OF 1 SEPTEMBER 2021

The board of directors (the "Board") of Biolidics Limited (the "Company" and together with its subsidiaries, the "Group") refers to the queries by SGX RegCo on the Company's announcements released on 1 September 2021 in relation to: (i) the appointment of Executive Director and Chief Executive Officer; (ii) the re-designation of Interim Chief Executive Officer to Chief Scientific Officer; (iii) the appointment of Director of Corporate Finance and Corporate Development; and (iv) changes to the composition of the Board (collectively, the "Announcements").

Unless otherwise defined, capitalised terms used in this announcement shall have the same meaning as ascribed to them in the Announcements.

Question 1: How were the new ED/CEO and Director of Corporate Finance and Corporate Development introduced to the Company?

Company's response:

Since the departure of the former CEO of the Company, Mr Lew Kwang Ping, in January 2020 as announced by the Company on 25 September 2019, the Board had considered potential candidates within the Group as well as external candidates with relevant experience and qualifications to assume the role of CEO of the Company. Prospective candidates outside the Group included those who were referred by senior management and Directors of the Group or other third parties. The new CEO, Mr Song Tang Yih ("Mr Song"), was introduced to the Company by the Group's Non-Executive Non- Independent Chairman, Mr Yee Pinh Jeremy.

The new Director of Corporate Finance and Corporate Development, Mr Hue Han Seung ("Mr Hue"), was referred to the Company by an external recruitment agency in August 2020 and was hired in November 2020 as Director of Corporate Finance/Corporate Development and Compliance of the Company. Mr Hue was not appointed as an executive officer of the Group ("EO") at that point in time and was only designated as an EO and assumed the role of Director of Corporate Finance and Corporate Development on 1 September 2021.

Question 2: What did the NC and Sponsor consider in assessing the suitability of the aforementioned individuals for their respective roles?

Company's response:

In assessing the suitability of Mr Song, the NC considered the following factors:

  1. Mr Song's professional and academic qualifications and working experience. In particular, Mr Song has experience in senior positions in both multi-national corporations as well as small and medium enterprises;
  2. Mr Song has demonstrated track record in managing companies listed on the SGX-ST; and
  3. Mr Song's disclosure and declaration forms.

In deciding to designate Mr Hue as an executive officer of the Group, the NC considered the following factors:

  1. Mr Hue's working experience as well as professional and academic qualifications;
  1. Mr Hue's performance in the role since he joined the Group in November 2020; and
  2. Mr Hue's disclosure and declaration forms.

Sponsor's response:

In assessing the suitability of the aforementioned individuals for their respective roles, the Sponsor had

  1. reviewed the disclosure and declaration forms of the individuals; (ii) considered the working experience and professional qualifications of the individuals as set out in their curricula vitae; (iii) performed name screening on the individuals against internal and external sources; and (iv) conducted due diligence interview with the individuals.

BY ORDER OF THE BOARD

Yee Pinh Jeremy

Non-ExecutiveNon-Independent Chairman

7 September 2021

This announcement has been prepared by the Company and has been reviewed by United Overseas Bank Limited (the "Sponsor") for compliance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist. This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Mr. Lim Hoon Khiat, Director, Equity Capital Markets, who can be contacted at 80 Raffles Place, #03-03 UOB Plaza 1, Singapore 048624, telephone: +65 6533 9898.

Attachments

  • Original document
  • Permalink

Disclaimer

Biolidics Ltd. published this content on 07 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 September 2021 11:21:01 UTC.